*102 Decision will be entered under Rule 155.
In connection with serving as an underwriter in a stock offering, P received cash and a warrant to purchase stock. P could not transfer or exercise the warrant until at least 13 months after the date of receipt, and there was no active trading of such warrants on any established market. P later sold the warrant to its sole shareholder. Held,
*200 Respondent determined a deficiency in petitioner's Federal income tax for the year ending March 31, 1982, in the amount of $ 195,782.54. After concessions, the remaining issue is whether petitioner realized capital *201 gain or ordinary income upon the*103 sale by petitioner to its sole shareholder of a warrant to purchase stock in another corporation.
PRELIMINARY MATTER
When the instant case was reached for trial, the parties had settled all but two of the items raised in the notice of deficiency. Trial then proceeded with respect to the issues involving those two items -- the characterization and timing of the income attributable to a warrant for the purchase of stock in Immuno Nuclear Corp., and a warrant for the purchase of stock in FilmTec Corp. The parties then filed simultaneous briefs and simultaneous reply briefs. In his reply brief, respondent stated that he "concedes the portion of the tax deficiency arising from the FilmTec warrant for purposes of this litigation. Respondent makes this concession without waiving its right to pursue the conceded portion through appropriate tax assessment procedures for the [year ending March 31, 1985]."
Although respondent's reply brief proffered to concede a significant portion of the deficiency for the year before us (ending March 31, 1982), petitioner filed a supplemental reply brief requesting the Court to render a decision on the merits and not to accept respondent's concession. *104 1 Petitioner, however, has cited no authority to support a rejection of respondent's proffered concession. Petitioner objects to respondent's offer of concession on the following grounds:
Respondent's shifting positions are prejudicial to the Petitioner. Petitioner has fully liquidated and is in the process of dissolving itself. It has retained only enough assets to pay any judgment in the pending Tax Court matter. It will not have sufficient assets to defend and pay a large judgment based upon the value of the warrant at the time of exercise.
The acceptance or rejection of a proffered concession is a matter within the discretion of the Court, and we should exercise our discretion in accordance with the "interest of justice." See*105
FINDINGS OF FACT
Some of the facts have been stipulated and are found accordingly. The stipulation of facts and attached exhibits are incorporated herein by this reference.
During all relevant periods, petitioner was a corporation having its principal place of business in Minneapolis, Minnesota. Petitioner is a stock brokerage firm which provided the services usually offered by such firms to their clients. Petitioner's sole shareholder is Jack W. Pagel.
In September 1977, petitioner served as underwriter for a stock offering by Immuno Nuclear Corp. (Immuno). In the stock offering, 235,000 Immuno shares were sold *106 at $ 1.50 per share, thus generating total proceeds of $ 352,500. Of that amount, Immuno received $ 310,200 and petitioner received $ 42,300 as commissions for the underwriting.
In connection with the underwriting, petitioner also received a warrant for the purchase of Immuno stock (the warrant). Petitioner paid Immuno a total of $ 10 for the warrant. Petitioner acquired the warrant pursuant to a clause in an underwriting agreement between Immuno and petitioner which provided that Immuno would sell to petitioner for $ 10 a warrant for (1) 17,000 Immuno shares, provided that petitioner sold at least 170,000 Immuno shares in the underwriting, or (2) 23,500 shares, in the event that petitioner sold all 235,000 shares made available in the offering.
The warrant provided that petitioner had the right to purchase 23,500 shares of Immuno common stock during the period beginning 13 months after October 5, 1977, the date of the warrant, and ending October 4, 1982, at the following prices per share:
*203 If purchased after October 4, 1978, 2 and on or before October 4, 1979, at $ 1.605;
If purchased thereafter and on or before October 4, 1980, at $ 1.710;
If purchased thereafter and*107 on or before October 4, 1981, at $ 1.815;
If purchased thereafter until expiration at $ 1.920.
Petitioner's right under the warrant to purchase the Immuno stock was not conditioned upon the future performance of any services by petitioner. Petitioner, however, could not assign, transfer, hypothecate, sell, or otherwise dispose of the warrant during the first 13 months after October 5, 1977.
When petitioner received the warrant, there was no active trading of Immuno warrants on any established market. Petitioner held the warrant in a segregated investment account from the time it acquired the warrant (October 1977) until October 1981. On October 2, 1981, petitioner sold the warrant to its sole shareholder, Mr. Pagel, for $ 314,900. On its Federal corporate income tax return for the year ending March 31, 1982, *108 petitioner reported the sale of the warrant as a capital gain in the amount of $ 314,890 (proceeds of $ 314,900 and basis of $ 10).
In the notice of deficiency, respondent recharacterized the gain from the sale of the warrant as ordinary income, based upon the following explanations:
1i. Schedule D (Capital Gains and Losses)
Since you were the underwriter for [Immuno] and were afforded the right to purchase their stock warrants at a bargain purchase price, your sale of these stock warrants should be reported as ordinary income. Therefore, we have not allowed capital gain treatment for the $ 314,890 gain resulting from the sale of these stock warrants.
1j. Underwriting Income
Ordinary income was increased * * * to reflect the sale of stock warrants of [Immuno] * * *. You were the underwriters * * *, and were afforded the right to purchase their stock warrents [sic] at a bargain purchase price. Therefore, you should recognize ordinary income at the time of exercise or transfer of the option in the amount of the difference between the fair market value and the exercise price.
*204 OPINION
The issue is whether petitioner's gain from the sale of the warrant to Mr. Pagel is *109 taxable as ordinary income or as capital gain. Respondent asserts that
Petitioner contends that respondent did not raise the applicability of
We shall begin our analysis with an exegesis of the general provisions of
We also have no doubt that petitioner received the warrant in connection with the underwriting services performed by it for Immuno; the parties in fact stipulated to that fact. Immuno certainly would not have issued the warrant to petitioner but for*113 the performance of the underwriting services. The fact that petitioner was not obligated to perform any future services for Immuno is immaterial in determining whether
Petitioner argues, however, that the fair market value of the warrant at the date of its transfer to petitioner was no greater than the $ 10 purchase price of the warrant, so the receipt of the warrant involved no compensation element to which
Extending past our preliminary conclusions, however, we note that several formulae have been developed by economists and other financial authors to value warrants. See Gann, "Taxation of Stock Rights and Other Options: Another Look at the Persistence of Palmer v. Commissioner,"
*116 We realize that the Kassouf formula does not take into account the temporal restrictions or the fact that the exercise prices are lower than $ 1.92 in earlier years, and we are not satisfied that the warrant necessarily was worth approximately $ 12,000 at the time of grant. 8 For example, we note Mr. Pagel's testimony that the warrant had some speculative value at the time it was granted to petitioner. Mr. Pagel stated that the restrictions associated with the warrant would have caused the speculative value of the warrant in 1977 to be no more than 20 percent of the price of the underlying stock. Twenty percent of the value of the underlying Immuno stock in 1977 equals $ 7,050 (23,500 x $ 1.50 per share x 20%), a value over 40 percent less than that given by the Kassouf formula.
*117 Mr. Pagel's use of the 20-percent rule-of-thumb estimate is consistent with regulations of the Minnesota Department of Commerce governing the maximum commissions any underwriter may receive for underwriting services. Those regulations provide that if "no market value exists [for an option or warrant], an option or warrant to acquire common stock shall be valued at 20 percent of the public offering price of such number of shares under option or warrant." *208 (Emphasis supplied.) Minn. R. 2875.3050, subpar. 2 (1983). Arguably, the 20-percent rule used by Mr. Pagel and the Minnesota regulations may be more accurate than the Kassouf formula in the case of a newly granted warrant still subject to restrictions imposed by State or Federal securities law, e.g., nontransferability for 1 year past the offering date (see Minn. R. 2875.3030C (1983)). Regardless of which method of valuation is more accurate, the Kassouf formula, the Minnesota regulations, or Mr. Pagel's estimate, we are convinced that any of these methods support our preliminary conclusion that the value of the warrant when acquired by petitioner was far in excess of the nominal $ 10 sum paid by petitioner. Accordingly, *118 we reject petitioner's argument and find that the fair market value of the warrant was greater than the $ 10 paid by petitioner and that there was an element of compensation inherent in the grant of the warrant.
(i) The option is transferable by the optionee;
(ii) The option is exercisable*119 immediately in full by the optionee;
(iii) The option or the property subject to the option is not subject to any restriction or condition (other than a lien or other condition to secure the payment of the purchase price) which has a significant effect upon the fair market value of the option; and
*209 (iv) The fair market value of the option privilege is readily ascertainable in accordance with
*120 The terms of the warrant are such that, until 13 months after the grant of the warrant, petitioner could not exercise the right to purchase Immuno stock and could not assign, transfer, hypothecate, sell, or otherwise dispose of the warrant. Nevertheless, petitioner's reply brief cites to
Petitioner's reply brief also cites
Furthermore, that regulation would require petitioner to recognize compensation income*122 at the time of the warrant's exercise or other disposition in an arm's-length transaction.
We now turn to deciding whether
*125 It is well established that a party may rely upon a theory if the opposing party has been provided with fair warning of the intention to base an argument upon that theory.
In the instant case, all evidence necessary for a legal determination under the
Moreover, as we noted above, the language in the notice of deficiency set forth the underlying rationale for attachment of the principles of
*128 We note also that in circumstances such as those herein, there is often an assertion that respondent has the burden of proof because he has alleged a "new matter." In the instant case, however, petitioner has not suggested that respondent should have the burden of proof with respect to
Retroactivity of
Having determined that
Petitioner argues that
We see no abuse of that discretion in the retroactive application of the
Validity of
We turn finally to what, in our view, is the only genuine issue in the instant case. We view petitioner's remaining contentions as being intertwined and, thus, we shall discuss the validity of regulation *132
Petitioner's final contention basically is that if any ordinary income must be recognized on account of the warrant, that ordinary income is recognizable upon the grant of the warrant in 1977, not upon the sale of the warrant to Mr. Pagel in 1981. In support of its case, petitioner notes that the amount which respondent proposes to tax to petitioner*133 as ordinary income from the sale of the warrant -- $ 314,890 -- is greater than the $ 310,200 received by Immuno from the 1977 stock offering. Petitioner argues that it is an "absurd and illegal proposition" for it to be taxed on compensation income 13 significantly greater in amount than the total proceeds of the stock offering to Immuno. While we do not agree that the proposition is illegal, we do agree that the application of
In 1961, the Treasury Department embraced the "readily ascertainable" standard with the promulgation of
*137 Thus, when Congress enacted
*138 We upheld the validity of
We begin by noting that we easily might have concluded that the warrant had a readily ascertainable fair market value at the date it was granted, and we might have made a finding of the warrant's value. We already have discussed the Kassouf formula, a generally well-respected method for approximating the normal value of a warrant without regard to whether the warrant is publicly traded. We have cited to a law review footnote which referred to several authors who have developed models for the valuation of stock options and warrants. See Gann, supra at 945 n. 86. *139 We even noted a State regulatory provision that provided a deemed value for an option or warrant. We would not think it too unwieldy for one or more of those methods to be adopted as constructs whereby nonpublicly traded options and warrants could be found to have readily ascertainable values.
Our role in the constitutional scheme, however, is not to draft the law; it is solely to interpret it. Indeed, we are constrained to uphold a regulation if it has a reasonable basis in the statutory history, even though a taxpayer's challenge to the policy behind the regulation has logical force.
The Code states only that
Congress did not specify any changes from the regulations' treatment of whether an option transferred in connection with the performance of services had a "readily ascertainable fair market value," when it had a clear opportunity to do so. Arguably, Congress' silence in that regard may amount to*142 a legislative enactment of the regulation provisions regarding whether options have a readily ascertainable fair market value. See
The conferees intend that in applying these rules for the future, the Service will make every reasonable effort to determine a fair market value for an option (i.e., in cases where similar property would be valued for*143 estate tax purposes ) where the employee irrevocably elects (by reporting the option as income on his tax return or in some other manner to be specified in regulations) to have the option valued at the time it is granted (particularly in the case of an option granted for a new business venture). The conferees intend that the Service will promulgate regulations and rulings setting forth as specifically as possible the criteria which will be weighed in valuing an option which the employee elects to value at the time it is granted.
Commentators have suggested that Congress' statement in 1976 indicates disapproval with the regulation provisions specifying when the value of an option is "readily ascertainable." See, e.g., Billman, "Nonstatutory Stock Options," 383 Tax Management A-8 (1984); Diamond & Salles, "The Receipt of Property for Services After the TRA," Tax Advisor 325, 334 (May 1988); Nolan, "Deferred Compensation and Employee Options Under the New
*221 The Senate version of the 1976 Act in fact contained a provision whereby taxpayers would have been able to elect to be taxed on the option at the time of grant, regardless of the difficulty of ascertaining the value of the option. See S. Rept. 94-938, 1976-3 C.B. (Vol. 3) 164. The fact that the provision from the Senate was deleted from the bill by the Conference committee (see H. Rept. 94-1515 (Conf.), supra at 438) indicates to us that Congress' intent was not necessarily to overrule the regulation provisions. Rather, the above quoted paragraph from the Conference report appears to have been included to assuage the members from the Senate who were unable to amass sufficient support for the provision to be passed into law. We read the quoted paragraph as only an invitation for Treasury to prescribe provisions that Congress, *145 itself, was unable to agree upon or adopt; we do not interpret it as a specific statement of congressional disapproval with the regulatory scheme.
In short, Congress' silence indicates to us that it did not perceive the regulatory provisions to be unreasonable or plainly contrary to congressional intent. Indeed, the regulations further a policy under which there is reasonable accuracy in the valuation of nonpublicly traded options. As we have stated in regard to the valuation rules of regulations
Surely, it cannot be considered unreasonable to require reasonable accuracy in the valuation of stock options. To hold otherwise would be to encourage estimates of fair market value of such rights on the basis of pure speculation and surmise.
Besides upsetting a regulatory scheme which has been the Treasury position for 25 years, a contrary finding would run counter to numerous cases, e.g.,
To reflect the parties' concessions,
Decision will be entered under Rule 155.
Footnotes
1. The parties' reply and supplemental briefs indicate that respondent's position with respect to the FilmTec warrant is that any income from the receipt or disposition of that warrant should be recognized in petitioner's tax year ending in 1985, not in the 1982 year herein in issue.↩
2. Although the warrant sets an exercise price as of Oct. 5, 1978, other provisions in the warrant preclude petitioner from exercising the warrant until Nov. 5, 1978, 13 months after the date of the warrant.↩
3. Unless otherwise indicated, all Code and section references are to the Internal Revenue Code of 1954 as amended and in effect during the relevant year. All Rule references are to the Tax Court Rules of Practice and Procedure.↩
4. See also
Cassetta v. Commissioner, T.C. Memo. 1979-385↩ .5. A "nonqualified stock option" is defined as one to which sec. 421 does not apply.
Sec. 1.83-7(a), Income Tax Regs.↩ Neither party has suggested that petitioner's warrant is an option to which sec. 421 applies, and we find that sec. 421 is inapplicable to the warrant.6. The obligation of a taxpayer to perform future services may affect when, not whether,
sec. 83 applies to a transfer of property. Seesec. 1.83-3(a) ,(b) , and(f), Income Tax Regs.↩ 7. Respondent's expert witness applied the complex Kassouf formula, as well as one known as the "Black-Scholes model," and took an average of the two results to determine a value for the FilmTec warrant.↩
8. We used an exercise price of $ 1.92, instead of the lower potential exercise prices, in order to give petitioner the benefit of the doubt and a lower valuation.
Using the complex Kassouf formula, set forth in Levine, supra↩ at 470, we also performed several calculations based upon the minimum exercise price ($ 1.605) and the maximum exercise price ($ 1.92), as well as upon several assumptions we made about the dividend rate and previous 11 months' stock prices for Immuno stock. Based upon those different assumptions, the values we calculated for the warrant ranged from approximately $ 8,900 to approximately $ 15,200.
9.
Sec. 1.83-7(b)(3), Income Tax Regs. , provides that in the determination of whether the value of an option is readily ascertainable, one must consider whether the value of the option may be measured with reasonable accuracy. That paragraph also provides that if an option has a readily ascertainable value, the amount of that value is to be determined by considering:(i) Whether the value of the property subject to the option can be ascertained;
(ii) The possibility of any ascertainable value of such property increasing or decreasing; and
(iii) The length of the period during which the option can be exercised.
By virtue of our holdings below, we need not further analyze
sec. 1.83-7(b)(3), Income Tax Regs.↩ 10. As in effect during the year in issue,
sec. 1236 provided as follows:SEC. 1236 . DEALERS IN SECURITIES.(a) Capital Gains. -- Gain by a dealer in securities from the sale or exchange of any security shall in no event be considered as gain from the sale or exchange of a capital asset unless --
(1) the security was, before the close of the day on which it was acquired (before the close of the following day in the case of an acquisition before January 1, 1982), clearly identified in the dealer's records as a security held for investment or if acquired before October 20, 1951, was so identified before November 20, 1951; and
(2) the security was not, at any time after the close of such day, held by such dealer primarily for sale to customers in the ordinary course of his trade or business.
* * * *
(c) Definition of Security. -- For purposes of this section, the term "security" means any share of stock in any corporation, certificate of stock or interest in any corporation, note, bond, debenture, or evidence of indebtedness, or any evidence of an interest in or right to subscribe to or purchase any of the foregoing.↩
11. See also Big "D"
Development Corp. v. Commissioner, T.C. Memo 1971-148">T.C. Memo. 1971-148 , affd. per curiam453 F.2d 1365">453 F.2d 1365↩ (5th Cir. 1972).12.
Sec. 1.83-8(b)(3), Income Tax Regs. , provides thatsec. 83 shall not apply to property received upon the exercise of an option granted before Apr. 22, 1969. That paragraph apparently is inapplicable to the warrant because petitioner never exercised the warrant (but seesecs. 1.83-7(a) and1.83-8(b)(3), Income Tax Regs.↩ ). In any event, the difference between the two effective dates is immaterial to the resolution of the instant case.13. Petitioner notes that respondent's position in this case would result in petitioner's recognizing $ 357,190 of ordinary compensation income on account of the underwriting ($ 314,890 net gain on the warrant plus $ 42,300 cash received at the time of the underwriting).↩
14. (c) Options with a readily ascertainable fair market value. -- (1) If there is granted an option to which this section applies and which has a readily ascertainable fair market value (determined in accordance with subparagraphs (2) and (3) of this paragraph) at the time the option is granted, the employee in connection with whose employment such option is granted realizes compensation at such time in an amount equal to the excess, if any, of such fair market value over any amount paid for the option. If an option to which this section applies does not have a readily ascertainable fair market value at the time the option is granted, the time when the compensation is realized and the amount of such compensation shall be determined under paragraph (d) of this section.
(2) Although options may have a value at the time they are granted, that value is ordinarily not readily ascertainable unless the option is actively traded on an established market. If an option is actively traded on an established market, the fair market value of such option is readily ascertainable for purposes of this section by applying the rules of valuation set forth in section 20.2031-2 of this chapter (the Estate Tax Regulations).
(3)(i) When an option is not actively traded on an established market, the fair market value of the option is not readily ascertainable unless the fair market value of the option can be measured with reasonable accuracy. For purposes of this section, if an option is not actively traded on an established market, the option does not have a readily ascertainable fair market value when granted unless the taxpayer can show that all of the following conditions exist:
(a) The option is freely transferable by the optionee;
(b) The option is exercisable immediately in full by the optionee;
(c) The option or the property subject to the option is not subject to any restriction or condition (other than a lien or other condition to secure the payment of the purchase price) which has a significant effect upon the fair market value of the option or such property; and
(d) The fair market value of the option privilege is readily ascertainable in accordance with subdivision (ii) of the subparagraph.↩
15. The unmistakable intention of the regulatory scheme is that
sec. 1.83-7, Income Tax Regs. , applies to post-1969 nonqualified options such as the warrant; however, it appears to us that a technical reading of the regulations would result in the facts of the instant case not being subject to any regulation provision. The terms ofsec. 83(e)(3) state thatsec. 83 does not apply to the transfer of an option without a readily ascertainable value, andsec. 83(a) , by its terms, applies only to a transfer of property in connection with the performance of services. It thus appears to us that an option without a readily ascertainable value at the time it was transferred by the recipient of services is not subject to taxation undersec. 83 and, thus, thesec. 83 regulations do not appear to provide the authority to tax the performer of the services. By default, sec. 61 therefore should control taxation of the property.Secs. 1.61-15(a) and1.61-2(d)(1) and(6), Income Tax Regs. , provide several exceptions and cross-references to thesec. 83 regulations; however, we are unable to find any provision in the sec. 61 regulations that applies to a post-1969 option without a readily ascertainable value to make it taxable under the sec. 61 regulations or any incorporation by reference of the scheme ofsec. 1.83-7, Income Tax Regs. We nevertheless believe that the regulatory scheme is intended to apply to options taxable under both
sec. 83 and sec. 61. We thus shall apply the scheme of thesec. 83 regulations as if it technically applied to options which fell out of the provisions ofsec. 83 into those of sec. 61. Even lacking such a regulatory scheme, we would reach the same conclusion as provided by that scheme pursuant to the relevant case law that otherwise exists. See p. 221, infra.We also note that although this issue may not have been squarely before the Court, the Eighth Circuit, the Court to which the instant case is appealable, affirmed the application of this regulatory scheme to a post-June 30, 1969, year in
Bagley v. Commissioner, 806 F.2d 169">806 F.2d 169 (8th Cir. 1986), affg.85 T.C. 663">85 T.C. 663↩ (1985).16. A holding that the regulation is invalid would upset a regulatory scheme for the taxation of options that has been in effect for 25 years, since the release of
T.D. 6696↩ in late 1963.